The greatest disparity in BC-specific survival was observed in women with HR+ HER2− tumors, with Black women having a 50% ...

During a Case-Based Roundtable® event, Michael J. Birrer, MD, PhD, moderated a discussion on what factors affect the need for ...

The US Food and Drug Administration (FDA) has approved a 420 mg dosage strength of Hercessi (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab). Hercessi, a HER2/neu receptor antagonist, is ...

近年来，HER2 在其他多种恶性肿瘤如胃癌、结直肠癌、非小细胞肺癌等中也逐渐「显山露水」，临床应用日益广泛。 1982 年，Robert Weinberg 团队从老鼠的神经母细胞瘤分离出一种致癌基因、命名为「neu 基因」。1985 年，Arthur Levinson 团队在人类基因组 DNA 库中找到了 ...

What Is HER2-Positive Breast Cancer? HER2-positive breast cancer is when breast cancer cells have a protein receptor called human epidermal growth factor receptor 2 (HER2). Normally, this protein ...

The Lung Cancer Research Foundation (LCRF) is pleased to announce its collaboration with Bayer Pharmaceuticals to fund two ...

Included studies compared survival between Black and White female patients with breast cancer within subtypes defined by hormone receptor and human epidermal growth factor receptor 2 (HER2)/neu (HER2; ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

Breast cancer remains the most common invasive cancer diagnosed in women in the United States, accounting for about one in three new female cancers each ye | Cancer ...

Groups Develop Request for Proposals for Research Grants Focused on Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations NEW YORK, Sept. 5, 2024 /PRNewswire/ -- The Lung Cancer ...

Scientists at Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer ...